An Explainer Interest in the next generation of AI is rising in the pharma industry. In this sector-specific guide, ArisGlobal’s Jason Bryant assesses agentic AI’s p...

The European Health Technology Assessment (HTA) landscape has long been characterised by heterogeneity in the clinical evaluation of health technologies after th...

Pick up an Ypsomed injection pen or autoinjector and the first things you notice are likely the technology, design, or ease of use. These are the tangible outcom...

Artificial intelligence (AI) is transforming how consumers interact with brands across every industry – including life sciences. While sectors like retail and en...

Regulatory changes, including the launch of ICH E6(R3) and Good Clinical Practice (GCP) updates, have highlighted the value of, and need for, risk-based quality ...

Post-translational modifications (PTMs) govern protein structure, function, and stability, influencing nearly every biological process. In biopharmaceuticals (bi...

In recent years, cardiovascular outcomes trials (CVOTs) have become prominent in studies of GLP-1 receptor agonists, demonstrating clinical heart health benefits...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revolutionised the management of type 2 diabetes mellitus (T2DM) and obesity. However, emerging eviden...

Automation as an Enabler in Medical Device Production The role of sensors in medical devices has grown dramatically over the past two decades. Once peripheral com...

In response to the evolving expectations of the biopharmaceutical industry, contract manufacturing organisations (CMOs) are facing mounting pressure to optimise ...